GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Quick Ratio

Intelligent Medicine Acquisition (Intelligent Medicine Acquisition) Quick Ratio : 0.17 (As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Intelligent Medicine Acquisition's quick ratio for the quarter that ended in Dec. 2022 was 0.17.

Intelligent Medicine Acquisition has a quick ratio of 0.17. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Intelligent Medicine Acquisition's Quick Ratio or its related term are showing as below:

IQMDU' s Quick Ratio Range Over the Past 10 Years
Min: 0.17   Med: 1.66   Max: 3.15
Current: 0.17

During the past 2 years, Intelligent Medicine Acquisition's highest Quick Ratio was 3.15. The lowest was 0.17. And the median was 1.66.

IQMDU's Quick Ratio is not ranked
in the Diversified Financial Services industry.
Industry Median: 1.185 vs IQMDU: 0.17

Intelligent Medicine Acquisition Quick Ratio Historical Data

The historical data trend for Intelligent Medicine Acquisition's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Medicine Acquisition Quick Ratio Chart

Intelligent Medicine Acquisition Annual Data
Trend Dec21 Dec22
Quick Ratio
3.15 0.17

Intelligent Medicine Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22
Quick Ratio Get a 7-Day Free Trial 0.08 3.15 0.75 0.32 0.17

Competitive Comparison of Intelligent Medicine Acquisition's Quick Ratio

For the Shell Companies subindustry, Intelligent Medicine Acquisition's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelligent Medicine Acquisition's Quick Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Intelligent Medicine Acquisition's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Intelligent Medicine Acquisition's Quick Ratio falls into.



Intelligent Medicine Acquisition Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Intelligent Medicine Acquisition's Quick Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Quick Ratio (A: Dec. 2022 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.188-0)/1.079
=0.17

Intelligent Medicine Acquisition's Quick Ratio for the quarter that ended in Dec. 2022 is calculated as

Quick Ratio (Q: Dec. 2022 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.188-0)/1.079
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intelligent Medicine Acquisition  (NAS:IQMDU) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Intelligent Medicine Acquisition Quick Ratio Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelligent Medicine Acquisition (Intelligent Medicine Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
9001 Burdette Road, Bethesda, MD, USA, 20817
Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken director 2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary director 3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon director, officer: CEO and CFO 9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball director 9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc 10 percent owner 9001 BURDETTE ROAD, BETHESDA MD 20817

Intelligent Medicine Acquisition (Intelligent Medicine Acquisition) Headlines